NIST-FDA Geneome Editing WorkshopDate: April 23 - 24, 2018
100 Bureau Drive
Gaithersburg, MD 20899
NIST and FDA are actively collaborating on projects that address regulatory and measurement challenges for regenerative medicine products and advanced therapies. These collaborations leverage NIST expertise in measurement sciences to address specific analytical scientific challenges as well as FDA regulatory science, research and review expertise in regenerative medicine products to ensure that the science and standards developed address significant regulatory challenges that recur across the field.
Targeted genome editing technologies are being leveraged across many sectors including in the development of novel therapeutics.